Table 1.

Clinicopathologic characteristics of patients (n = 13)

Basic characteristic	n = 13
Median age (years,range)	47 (22–78)
Gender (male:female)	8:5
Tumor location (n, %)
Parotid gland	9 (69.23)
Submandibular gland	3 (23.08)
Palate	1 (7.69)
Clinical manifestation (n, %)
Painless masses	13 (100%)
Tumor characteristics
Diameter(cm,range)	2.2 (1.5-5.0)
Texture	Hard
Boundary	Clearer
Activity	Good
T stage(n,%)
T1	3 (23.08)
T2	6(46.15)
T3	3(23.08)
T4	1(7.69)
N stage(n,%)
N0	11(84.62)
N1	1(7.69)
N2	1(7.69)
N3	0
M stage(n,%)
M0	13(100)
M1	0
IHC(n,%)
Mammaglobin(+)	11 (11/13)
S-100(+)	13 (13/13)
MUC-4(+)	6 (6/10)
CK7(+)	13 (13/13)
AE1/AE3(+)	13 (13/13)
P63(-)	9 (9/12)
Dog-1(-)	12 (12/13)
Ki-67	10 (2–15%)
FISH genetic testing(n,%)
ETV6-NTRK3 Fusion	7 (7/7)